Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
057
|
Date of Entry 12/20/2021
|
FR Recognition Number
|
3-177
|
Standard | |
ASTM F2606-08 (Reapproved 2021) Standard Guide for Three-Point Bending of Balloon-Expandable Vascular Stents and Stent Systems |
|
Scope/Abstract1.1 This guide provides guidelines for quantitatively characterizing balloon-expandable stent and stent system flexibility using three-point bending procedures. Guidelines are provided for characterizing deployed stent flexibility, and for characterizing pre-deployment stent system flexibility in the region of the stent and balloon....
|
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized because it is scientifically and technically valid and not in conflict with existing regulatory policies. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
N/A |
Stent, Coronary |
Class 3
|
MAF
|
N/A |
Stent, Carotid |
Class 3
|
NIM
|
N/A |
Stent, Renal |
Class 3
|
NIN
|
N/A |
Stent, Iliac |
Class 3
|
NIO
|
N/A |
Stent, Superficial Femoral Artery |
Class 3
|
NIP
|
N/A |
Coronary Drug-Eluting Stent |
Class 3
|
NIQ
|
|
Relevant FDA Guidance and/or Supportive Publications*
1. Select Updates for Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems, Guidance for Industry and Food and Drug Administration Staff, Issued August 2015.
2. Guidance for Industry and FDA Staff: Non-Clinical Engineering Tests and Recommended Labeling for Intravascular Stents and Associated Delivery Systems, Issued April 2010.
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |